HighBeam QuickSearch
Get direct access to articles and research when you
add HighBeam to your browser's search toolbar.
|
-
-
Aastrom Biosciences Signs Sublicensing Agreement With Corning.
-
PR Newswire; Dec 12, 2002; 700+ Words
...Support Corning Life Sciences' Applications -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced that it has...and microplates for cell analysis. About Aastrom Biosciences, Inc. Aastrom Biosciences, Inc. (NasdaqSC: ASTM) is...
-
-
Aastrom Biosciences Appoints New Chief Financial Officer.
-
PR Newswire; Jun 20, 2005; 700+ Words
...June 20 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. announced today the appointment of Gerald...transition and orientation of Mr. Brennan. About Aastrom Biosciences, Inc. Aastrom Biosciences, Inc. is developing patient...
-
-
Aastrom Biosciences Receives Patent for Adult Bone Marrow Stem Cells; - Patent Expands Intellectual Property for Producing Therapeutic Cells -.
-
PR Newswire; Feb 27, 2002; 700+ Words
ANN ARBOR, Mich. -- Aastrom Biosciences, Inc. announced today that it received from the...cells for multiple medical indications. About Aastrom Biosciences, Inc. Aastrom is a leader in the development of proprietary...
-
-
Aastrom Biosciences Receives Patent for Transplantation Use of Its Stem Cell Products; -- Patent Covers Bone Marrow, Blood and Cord Blood-Sourced Products --.
-
PR Newswire; Mar 3, 2004; 700+ Words
Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that it has received...vascular tissue in diabetic and heart disease patients." About Aastrom Biosciences, Inc. Aastrom Biosciences, Inc. (NasdaqSC: ASTM) is a late-stage...
-
-
Aastrom Biosciences Receives Patent Expanding Coverage for its Single-Pass Perfusion Technology.
-
PR Newswire; Jan 14, 2005; 700+ Words
...Stem Cell Population to Dendritic Cells -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that...novel cell- based therapeutics." About Aastrom Biosciences, Inc. Aastrom Biosciences, Inc. (NasdaqSC: ASTM) is...
-
-
Aastrom Biosciences Completes CE Mark Requirements for Third Dendritic Cell Therapy Product; -- Expands Aastrom's Cell Production Products Business --.
-
PR Newswire; Aug 21, 2003; 700+ Words
Aastrom Biosciences, Inc. (NasdaqSC: ASTM) today announced...a wholly owned subsidiary of Aastrom Biosciences, Inc., located in Berlin, Germany...49-30-2065-9165. About Aastrom Biosciences, Inc. Aastrom Biosciences, Inc...
-
-
AASTROM BIOSCIENCES, INC. ANNOUNCES US PATENT FOR PROCESS TO OPTIMIZE EX VIVO GENE TRANSFER
-
PR Newswire; Jul 10, 1996; 700+ Words
...July 10 /PRNewswire/ -- AASTROM Biosciences, Inc. announced today the issuance...disposable cell container. AASTROM Biosciences, Inc., headquartered in Ann...President, Marketing of AASTROM Biosciences, Inc., 313-930-5555, or...
-
-
Aastrom Biosciences Inc. and Cobe BCT initiate stem cell clinical trial in Europe.
-
Business Wire; Mar 11, 1997; 700+ Words
...in cancer patients undergoing chemotherapy Aastrom Biosciences Inc. ("Aastrom") (Nasdaq:ASTM) and its strategic partner...ablative chemotherapy to treat their disease. Aastrom Biosciences Inc. is headquartered in Ann Arbor. The company...
-
-
Aastrom Biosciences Receives NIH Grant to Optimize its Stem Cell Products for the Generation of Normal Human Tissue.
-
PR Newswire; Jun 18, 2003; 700+ Words
Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that the Company has...unique for a growing number of clinical applications. About Aastrom Biosciences, Inc. Aastrom Biosciences, Inc. (NasdaqSC: ASTM) is a late-stage...
-
-
Aastrom Biosciences Receives Manufacturing License at European Pilot Facility for Production of Proprietary Bone Marrow Stem Cell Products.
-
PR Newswire; May 10, 2006; 700+ Words
...May 10 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. announced today that it has received a human...regenerating certain normal healthy tissues. About Aastrom Biosciences, Inc. Aastrom Biosciences, Inc. is developing products...
-
-
Aastrom Biosciences Initiates Bone Graft Clinical Trial at Lead U.S. Site; Evaluation of Stem Cell Product for Leg Fracture Healing Begins in Chicago.
-
PR Newswire; Jan 14, 2004; 700+ Words
Aastrom Biosciences, Inc. (NasdaqSC: ASTM) today announced that its U.S. clinical...Aastrom's collaboration partner for this trial. About Aastrom Biosciences, Inc. Aastrom Biosciences, Inc. (NasdaqSC: ASTM) is a late-stage...
-
-
Aastrom Biosciences Announces Initiation of Clinical Trial for Sinus Lift Bone Graft Procedures in Spain.
-
PR Newswire Europe; Oct 21, 2004; 700+ Words
...Build New Bone Tissue for Dental Implants -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM), and the Institut de...normal healthy bone marrow tissues. About Aastrom Biosciences, Inc. Aastrom Biosciences, Inc. (NasdaqSC: ASTM) is...
-
-
Aastrom Biosciences Enters Into Common Stock Purchase Agreement With Fusion Capital.
-
PR Newswire; Nov 27, 2002; 700+ Words
Aastrom Biosciences, Inc. (NasdaqSC: ASTM), a leader in cell therapies for tissue...please visit http://www.fusioncapital.com/. About Aastrom Biosciences, Inc. Aastrom develops unique cell-based products through proprietary...
-
-
Herbert S. Schwartz, M.D. Appointed to Aastrom Biosciences' Technology Review Board.
-
PR Newswire; Oct 14, 2003; 700+ Words
Aastrom Biosciences, Inc. (NasdaqSC: ASTM) today announced the appointment of...N. Wolff, Aastrom's head of medical research. About Aastrom Biosciences, Inc. Aastrom Biosciences, Inc. (NasdaqSC: ASTM) is a late-stage...
-
-
Warren Chaunce Bogard, Jr., Ph.D. Appointed to Aastrom Biosciences' Board of Directors.
-
PR Newswire; Feb 4, 2005; 700+ Words
Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that Warren Chaunce...a Ph.D. in Biochemistry from Purdue University. About Aastrom Biosciences, Inc. Aastrom Biosciences, Inc. (NasdaqSC: ASTM) is developing treatments...
-
-
Aastrom Biosciences to Hold Investor Conference Call.
-
PR Newswire; Jan 31, 2005; 700+ Words
Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that it will host an...1009961, and archived for 90 days at the same site. About Aastrom Biosciences, Inc. Aastrom Biosciences, Inc. (NasdaqSC: ASTM) is developing treatments...
-
-
Alan L. Rubino Elected to Aastrom Biosciences' Board of Directors.
-
PR Newswire; Sep 30, 2005; 700+ Words
...Sept. 30 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. announced today that Alan L. Rubino, a...for her contributions and service. About Aastrom Biosciences, Inc. Aastrom Biosciences, Inc. is developing patient...
-
-
Aastrom Biosciences and Stanford University Announce Immunotherapy Collaboration for Hodgkin's Disease.
-
PR Newswire; May 30, 2003; 700+ Words
Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that it has entered...the development of a successful cancer therapy." About Aastrom Biosciences, Inc. Aastrom Biosciences, Inc. (NasdaqSC: ASTM) is a late-stage...
-
-
Aastrom Biosciences Forms European Clinical Network for Stem Cell Transplant Product; - Aastrom's SC-I Bone Marrow Stem Cells Intend to Improve Cancer Treatment Options -.
-
PR Newswire; Feb 28, 2002; 700+ Words
ANN ARBOR, Mich. -- Aastrom Biosciences, Inc. , announced today the...wholly-owned subsidiary of Aastrom Biosciences, Inc., located in Berlin...products in Europe. About Aastrom Biosciences, Inc. Aastrom is a leader in...
-
-
Aastrom Biosciences Completes Second CE Marked Dendritic Cell Therapy Product; - Product to Provide Foothold in Novel Cancer Therapy Field -.
-
PR Newswire; Feb 14, 2002; 700+ Words
ANN ARBOR, Mich. -- Aastrom Biosciences, Inc. , announced today that...wholly-owned subsidiary of Aastrom Biosciences, Inc., located in Berlin...products in Europe. About Aastrom Biosciences, Inc. Aastrom is a leader in...
|
|